This study suggests that elevated NDPK-B expression, through activation of SK4 channels, would contribute to arrhythmogenesis in ACM and that NDPK-B may be a potential therapeutic point for the treatment of arrhythmias in ACM patients [40]. Here, NME2 is linked to cardiac arrhythmia.